Lenalidomide Mylan - direct healthcare professional communication (DHPC)

lenalidomide

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Lenalidomide Mylan (lenalidomide): potential for damaged capsules and precautionary handling measures

Key facts

• Medicine name:
  Lenalidomide Mylan
• Active substance:
  lenalidomide
• Therapeutic area (MeSH):
  Multiple Myeloma
• DHPC type:
  Quality defect
• Human ATC codes:
  L04AX07
• Dissemination date:
  29/10/2025